Piramal Pharma Limited — Important, 12-05-2025: General Updates

Piramal Pharma has announced a board meeting on the financial results for the quarter and half-year. Its Turbhe manufacturing facility successfully cleared the US FDA inspection with a Voluntary Action Indicated (VAI) status, signaling compliance with some observations to address. This supports continued operations and market access in the US, positively underpinning the company’s global pharma business.